High-density genotyping of STAT4 reveals multiple haplotypic associations with Systemic lupus erythematosus in different racial groups

Arthritis and Rheumatism

Volumn 60, Issue 4, 2009, Pages 1085-1095

  Namjou, Bahram ^a   Sestak, Andrea L ^a   Armstrong, Don L ^b   Zidovetzki, Raphael ^b   Kelly, Jennifer A ^a   Ciobanu, Noam Jacob Voicu ^c   Kaufman, Kenneth M ^c   Ojwang, Joshua O ^d   Ziegler, Julie ^e   Quismorio Jr , Francesco P ^c   Reiff, Andreas ^c   Myones, Barry L ^f   Guthridge, Joel M ^a   Nath, Swapan K ^a   Bruner, Gail R ^a   Mehrian Shai, Ruth ^c   Silverman, Earl ^g   Klein Gitelman, Marisa ^h   Mccurdy, Deborah ⁱ   Wagner Weiner, Linda ^j   Nocton, James J ^k   Putterman, Chaim ^l   Bae, Sang Cheol ^m   Kim, Yun Jung ^m   Petri, Michelle ⁿ   Reveille, John D ^o   Vyse, Timothy J ^p   Gilkeson, Gary S ^q   Kamen, Diane L ^q   Alarcón Riquelme, Marta E ^r   Gaffney, Patrick M ^a   Moser, Kathy L ^a   Merrill, Joan T ^a   Scofield, R Hal ^a   James, Judith A ^a   Langefeld, Carl D ^e   Harley, John B ^d   Jacob, Chaim O ^c,s   more..

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^e WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

^h NORTHWESTERN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CHICAGO   (United States)

^k MEDICAL COLLEGE OF WISCONSIN   (United States)

^l ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^m Hanyang University Hospital for Rheumatic Diseases   (South Korea)

ⁿ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF TEXAS   (United States)

^p HAMMERSMITH HOSPITAL   (United Kingdom)

^q MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^r UPPSALA UNIVERSITY   (Sweden)

^s UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; STAT1 PROTEIN; STAT4 PROTEIN;

AFRICAN AMERICAN; ARTICLE; CHROMOSOME 2; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HISPANIC; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PREVALENCE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

AFRICAN AMERICANS; ASIAN AMERICANS; ASIAN CONTINENTAL ANCESTRY GROUP; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HISPANIC AMERICANS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STAT1 TRANSCRIPTION FACTOR; STAT4 TRANSCRIPTION FACTOR; UNITED STATES;

EID: 65249157054     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.24387     Document Type: Article

References (51)

1. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003;100:2610-5.
2. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003;197:681-5.
3. Crow MK, Kirou KA, Wohlgemuth J. Microarray analysis of interferon-regulated genes in SLE. Autoimmunity 2003;36:481-90.
4. Baechler EC, Gregersen PK, Behrens TW. The emerging role of interferon in human systemic lupus erythematosus. Curr Opin Immunol 2004;16:801-7.
5. Ronnblom LE, Alm GV, Oberg KE. Possible induction of systemic lupus erythematosus by interferon-a treatment in a patient with a malignant carcinoid tumour. J Intern Med 1990;227:207-10.
6. Gota C, Calabrese L. Induction of clinical autoimmune disease by therapeutic interferon-α. Autoimmunity 2003;36:511-8.
7. Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK. High serum IFN-a activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun 2007;8:492-502.
8. Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW, et al. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 2006;38:550-5.
9. Cunninghame Graham DS, Manku H, Wagner S, Reid J, Timms K, Gutin A, et al. Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation. Hum Mol Genet 2007;16:579-91.
10. Graham RR, Kyogoku C, Sigurdsson S, Vlasova IA, Davies LR, Baechler EC, et al. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 2007;104:6758-63.
11. Jacob CO, van Der Meide PH, McDevitt HO. In vivo treatment of (NZB X NZW) F1 lupus-like nephritis with monoclonal antibody to 7 interferon. J Exp Med 1987;166:798-802.
12. Ozmen L, Roman D, Fountoulakis M, Schmid G, Ryffel B, Garotta G. Experimental therapy of SLE: the treatment of NZB/W mice with mouse soluble interferon-7 receptor inhibits the onset of glomerulonephritis. Eur J Immunol 1995;25:6-12.
13. Haas C, Ryffel B, Le Hir M. IFN-7 receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW) F1 mice. J Immunol 1998;160:3713-8.
14. Levy DE, Darnell JE Jr. Stats: transcriptional control and biologic impact [review]. Nat Rev Mol Cell Biol 2002;3:651-62.
15. Murray PJ. The JAK-STAT signaling pathway: input and output integration [review]. J Immunol 2007;178:2623-9.
16. Ihle JN. The Stat family in cytokine signaling [review]. Curr Opin Cell Biol 2001;13:211-7.
17. Kim HS, Lee MS. STAT1 as a key modulator of cell death [review]. Cell Signal 2007;19:454-65.
18. Meraz MA, White JM, Sheehan KC, Bach EA, Rodig SJ, Dighe AS, et al. Targeted disruption of the Statl gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 1996;84:431-42.
19. Chapgier A, Boisson-Dupuis S, Jouanguy E, Vogt G, Feinberg J, Prochnicka-Chalufour A, et al. Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease. PLoS Genet 2006;2: el31.
20. Kaplan MH. STAT4: a critical regulator of inflammation in vivo. Immunol Res 2005;31:231-42.
21. Moser KL, Neas BR, Salmon JE, Yu H, Gray-McGuire C, Asundi N, et al. Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome lq in African-American pedigrees. Proc Natl Acad Sci U S A 1998;95:14869-74.
22. Cantor RM, Yuan J, Napier S, Kono N, Grossman JM, Hahn BH, et al. Systemic lupus erythematosus genome scan: support for linkage at Iq23, 2q33, 16ql2-13, and 17q21-23 and novel evidence at 3p24, 10q23-24, 13q32, and 18q22-23. Arthritis Rheum 2004; 50:3203-10.
23. Remmers EF, Plenge RM, Lee AT, Graham RR, Horn G, Behrens TW, et al. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007;357:977-86.
24. Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, et al. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008;2:204-10.
25. Horn G, Graham RR, Modrek B, Taylor KE, Ortmann W, Gamier S, et al. Association of systemic lupus erythematosus with C8orfl3- BLK and ITGAM-ITGAX. N Engl J Med 2008;358:900-9.
26. Kaufman KM, Kelly JA, Herring BJ, Adler AJ, Glenn SB, Namjou B, et al. Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus. Arthritis Rheum 2006;54:2533-40.
27. Jacob CO, Reiff A, Armstrong DL, Myones BL, Silverman E, Klein-Gitelman M, et al. Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform. Arthritis Rheum 2007;56:4164-73.
28. Alarcon GS, McGwin G Jr, Petri M, Ramsey-Goldman R, Fessler B, Vila LM, et al. Time to renal disease and end-stage renal disease in PROFILE: a multiethnic lupus cohort. PLoS Med 2006;3:e396.
29. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
30. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a toolset for whole-genome association and population-based linkage analysis. Am J Hum Genet 2007;81: 559-75.
31. Barrett JC, Fry B, Mailer J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21: 263-5.
32. Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003;100:9440-5.
33. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006;38:904-9.
34. Cassidy JT. Systemic lupus erythematosus. In: Cassidy JT, Petty RE, editors. Textbook of pediatric rheumatology. Philadelphia: Elsevier Saunders; 1996. p. 329-406.
35. Lehman TJ. Systemic lupus erythematosus in childhood and adolescence. In: Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. Philadelphia: Lippincott Williams and Wilkins; 2002. p. 863-84.
36. Lee HS, Remmers EF, Le JM, Kastner DL, Bae SC, Gregersen PK. Association of STAT4 with rheumatoid arthritis in the Korean population. Mol Med 2007; 13:455-60.
37. Korman BD, Alba MI, Le JM, Alevizos I, Smith JA, Nikolov NP, et al. Variant form of STAT4 is associated with primary Sjögren's syndrome. Genes Immun 2008;9:267-70.
38. Kaplan MH, Sun YL, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat-4- deficient mice. Nature 1996;382:174-7.
39. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Thl, Th2 and more. Immunol Today 1996;17:138-46
40. Chitnis T, Najafian N, Benou C, Salama AD, Grusby MJ, Sayegh MH, et al. Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J Clin Invest 2001;108:739-47.
41. Finnegan A, Grusby MJ, Kaplan CD, O'Neill SK, Eibel H, Koreny T, et al. IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms. J Immunol 2002;169: 3345-52.
42. Simpson SJ, Shah S, Comiskey M, de Jong YP, Wang B, Mizoguchi E, et al. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat) -4 pathway, but is not conditional on interferon γ expression by T cells. J Exp Med 1998;187:1225-34.
43. Afanasyeva M, Wang Y, Kaya Z, Stafford EA, Dohmen KM, Sadighi Akha AA, et al. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-7-independent pathway. Circulation 2001; 104:3145-51.
44. Yang Z, Chen M, Ellett JD, Fialkow LB, Carter JD, McDuffie M, et al. Autoimmune diabetes is blocked in Stat4-deficient mice. J Autoimmun 2004;22:191-200.
45. Ferber IA, Brocke S, Taylor-Edwards C, Ridgway W, Dinisco C, Steinman L, et al. Mice with a disrupted IFN-7 gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 1996;156:5-7.
46. Wang W, Ostlie NS, Conti-Fine BM, Milani M. The susceptibility to experimental myasthenia gravis of STAT6-/- and STAT4-/- BALB/c mice suggests a pathogenic role of Thl cells. J Immunol 2004;172:97-103.
47. Land KJ, Moll JS, Kaplan MH, Seetharamaiah GS. Signal transducer and activator of transcription (Stat) -6-dependent, but not Stat4-dependent, immunity is required for the development of autoimmunity in Graves' hyperthyroidism. Endocrinology 2004; 145:3724-30.
48. Jacob CO, Zang S, Li L, Ciobanu V, Quismorio F, Mizutani A, et al. Pivotal role of Stat4 and Stat6 in the pathogenesis of the lupus-like disease in the New Zealand mixed 2328 mice. J Immunol 2003;171:1564-71.
49. Singh RR, Saxena V, Zang S, Li L, Finkelman FD, Witte DP, et al. Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J Immunol 2003;170: 4818-25.
50. Sigurdsson S, Nordmark G, Gamier S, Grundberg E, Kwan T, Nilsson O, et al. A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Hum Mol Genet 2008;18:2868-76.
51. Taylor KE, Remmers EF, Lee AT, Ortmann WA, Plenge RM, Tian C, et al. Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet 2008;4:el000084.